Literature DB >> 16846458

Humoral immune responses and CD27+ B cells in children with DiGeorge syndrome (22q11.2 deletion syndrome).

A Finocchi1, S Di Cesare, M L Romiti, C Capponi, P Rossi, R Carsetti, C Cancrini.   

Abstract

The spectrum of T-cell abnormalities in 22q11.2 syndrome is quite broad, ranging from profound and life threatening to non-existent defects. Humoral abnormalities have been described in some of these patients, although no data are currently available on their phenotypical and functional B cell subsets. The purpose of this study was to investigate humoral immune function in a cohort of 13 children with DiGeorge syndrome by immunophenotyping B and by analysing their functionality in vivo. Humoral immunity was assessed by serum immunoglobulin evaluation, IgG subclasses determination, and testing of specific antibody titers to recall antigens. B cells were analyzed by flow cytometry and the relevant percentage of membrane surface expression of CD27, IgM, IgD was evaluated. In our cohort, one of 13 children (7.7%) had a complete IgA deficiency, four of 13 (30.7%) had minor immunoglobulin abnormalities, and five (38%) had an impaired production of specific antibodies. Five of 13 children (38%) had recurrent infections. Interestingly, peripheral CD27+ B cells were reduced in our patients as compared with age-matched healthy controls, and this decrement was statistically significant for IgM+ IgD+ CD27+ B cells. Immunoglobulin abnormalities were associated with the occurrence of recurrent infections. We conclude that a significant proportion of patients with DiGeorge syndrome have defective humoral immunity, which may represent an additional pathogenic mechanism underlying the increased susceptibility to infections. Whether the decreased CD27+ B-cell subset might be one of the defects that contribute to impaired humoral immunity, and to susceptibility to infection remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16846458     DOI: 10.1111/j.1399-3038.2006.00409.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  20 in total

1.  Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

Authors:  R Zemble; E Luning Prak; K McDonald; D McDonald-McGinn; E Zackai; K Sullivan
Journal:  Clin Immunol       Date:  2010-05-15       Impact factor: 3.969

2.  Resolution of Primary Immune Defect in 22q11.2 Deletion Syndrome.

Authors:  Yiwa Suksawat; Achara Sathienkijkanchai; Jittima Veskitkul; Orathai Jirapongsananuruk; Nualanong Visitsunthorn; Pakit Vichyanond; Punchama Pacharn
Journal:  J Clin Immunol       Date:  2017-04-20       Impact factor: 8.317

Review 3.  Immunological aspects of 22q11.2 deletion syndrome.

Authors:  A R Gennery
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

Review 4.  CHARGE syndrome: a review of the immunological aspects.

Authors:  Monica T Y Wong; Elisabeth H Schölvinck; Annechien J A Lambeck; Conny M A van Ravenswaaij-Arts
Journal:  Eur J Hum Genet       Date:  2015-02-18       Impact factor: 4.246

5.  Uveitis in DiGeorge syndrome: a case of autoimmune ocular inflammation in a patient with deletion 22q11.2.

Authors:  Chloe Gottlieb; Zhuqing Li; Gulbu Uzel; Robert B Nussenblatt; H Nida Sen
Journal:  Ophthalmic Genet       Date:  2010-03       Impact factor: 1.803

6.  [Associated diseases and differential diagnostic considerations in childhood atopic eczema].

Authors:  C Jenneck; R Foelster-Holst; T Hagemann; N Novak
Journal:  Hautarzt       Date:  2007-02       Impact factor: 0.751

7.  Persistent low thymic activity and non-cardiac mortality in children with chromosome 22q11.2 microdeletion and partial DiGeorge syndrome.

Authors:  P Eberle; C Berger; S Junge; S Dougoud; E Valsangiacomo Büchel; M Riegel; A Schinzel; R Seger; T Güngör
Journal:  Clin Exp Immunol       Date:  2008-11-24       Impact factor: 4.330

8.  22q11.2 Deletion Syndrome due to a Translocation t(6;22) in a Patient Conceived via in vitro Fertilization.

Authors:  Anelisa Gollo Dantas; Adriana Bortolai; Mariana Moysés-Oliveira; Sylvia Takeno Herrero; Adriana Azoubel Antunes; Beatriz Tavares Costa-Carvalho; Vera Ayres Meloni; Maria Isabel Melaragno
Journal:  Mol Syndromol       Date:  2015-11-14

9.  Crk Adaptor Proteins Regulate NK Cell Expansion and Differentiation during Mouse Cytomegalovirus Infection.

Authors:  Tsukasa Nabekura; Zhiying Chen; Casey Schroeder; Taeju Park; Eric Vivier; Lewis L Lanier; Dongfang Liu
Journal:  J Immunol       Date:  2018-04-04       Impact factor: 5.422

10.  Vitamin D status and the immune assessment in 22q11.2 deletion syndrome.

Authors:  A Legitimo; V Bertini; G Costagliola; G I Baroncelli; R Morganti; A Valetto; R Consolini
Journal:  Clin Exp Immunol       Date:  2020-04-16       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.